MyFinsight
Home
Blog
About
Contact
Net (loss) income
attributable to roivant...
-$299,771K
(-74.30%↓ Y/Y)
Net loss
attributable to...
-$98,136K
(46.88%↑ Y/Y)
Net (loss) income
-$397,907K
(-11.54%↓ Y/Y)
(loss) income from
continuing operations, net...
-$397,907K
(45.47%↑ Y/Y)
(loss) income from
continuing operations...
-$264,578K
(61.18%↑ Y/Y)
Income tax expense
$133,329K
(176.77%↑ Y/Y)
Interest income
$178,109K
(-31.07%↓ Y/Y)
Change in fair value of
investments
$105,046K
(90.35%↑ Y/Y)
Gain on
deconsolidation of subsidiaries
$11,027K
(254.79%↑ Y/Y)
Other (income)
expense, net
$4,012K
(137.42%↑ Y/Y)
(loss) income from
operations
-$515,068K
(48.66%↑ Y/Y)
Gain on litigation
settlement
$770,235K
Revenue
$8,260K
(-71.57%↓ Y/Y)
Change in fair value of
liability instruments
-$47,704K
(-402.77%↓ Y/Y)
Total operating
expenses
$1,293,563K
(13.20%↑ Y/Y)
Research and development
(includes 47,867, 39,780...
$681,812K
(23.87%↑ Y/Y)
General and
administrative (includes...
$610,466K
(3.22%↑ Y/Y)
Cost of revenues
$1,285K
(41.05%↑ Y/Y)
Back
Back
Income Statement
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
source: myfinsight.com